Literature DB >> 33618054

Hypertension in pregnancy: Prevalence, risk factors and outcomes for women birthing in Ireland.

Lisa Corrigan1, Anne O'Farrell2, Patrick Moran3, Deirdre Daly3.   

Abstract

OBJECTIVES: The purpose of this study was to identify the number of pregnancies affected by hypertension in Ireland and report on possible risk factors and adverse pregnancy outcomes for women and their babies. STUDY
DESIGN: Data on maternity hospital discharges for women giving birth in Ireland in 2016 were extracted from the national Hospital In-Patient Enquiry data system. Women with a diagnosis of a hypertensive disorder of pregnancy were identified using relevant ICD codes. Descriptive statistics were used to present prevalence, and Pearson's Chi-square and multivariable regression analyses were conducted to identify risk factors and pregnancy outcomes. Differences between proportions were analysed by Pearson's Chi-squared test of independence.
RESULTS: Of 60,188 maternities reported for the year 2016, 5.9% of women (n = 3531) had a hypertensive disorder of pregnancy and 4.6% (n = 2790) had pre-eclampsia. Rates were higher among women with pre-existing diabetes, gestational diabetes, obesity and those aged ≥40 years. After adjusting for maternal age, pre-existing DM, GDM, obesity and tobacco use, obesity (AOR 4.3; 95% CI: 3.2-5.7; p < 0.001), pre-existing diabetes (AOR 3.5; 95% CI: 2.5-4-9; p < 0.001), gestational diabetes (AOR 1.5; 95% CI: 1.3-1.8; p < 0.001) and being aged ≥40 years (AOR 1.5; 95% CI: 1.3-1.7; p < 0.001) remained significantly associated with being diagnosed with a hypertensive disorder of pregnancy in the Republic of Ireland.
CONCLUSION: In Ireland where maternal age at childbirth is increasing, the association of hypertension with advancing age will undoubtedly contribute to a greater prevalence of hypertensive disorders of pregnancy and their potential adverse outcomes for pregnant women and their babies. This retrospective study highlights the prevalence rates in Ireland while also identifying possible risk factors and associated adverse pregnancy outcomes. They pinpoint the need for further research to look in more detail at risk factors and adverse outcomes for the 79% (n = 2790) of women presenting with pre-eclampsia among this large nationally representative sample of women.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gestational diabetes; HELLP syndrome; Hypertension; Obesity; Pre-eclampsia; Pregnancy

Year:  2021        PMID: 33618054     DOI: 10.1016/j.preghy.2021.02.005

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  6 in total

1.  The Impact of the One-Day Clinic Diabetes Mellitus Management Model on Perinatal Outcomes in Patients with Gestational Diabetes Mellitus.

Authors:  Yan-Min Cao; Wei Wang; Na-Na Cai; Min Ma; Jie Liu; Peng Zhang; Lian Xue; Yuan-Yuan Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-06       Impact factor: 3.168

2.  Maternal Hypertension Increases Risk of Preeclampsia and Low Fetal Birthweight: Genetic Evidence From a Mendelian Randomization Study.

Authors:  Maddalena Ardissino; Eric A W Slob; Ophelia Millar; Rohin K Reddy; Laura Lazzari; Kiran Haresh Kumar Patel; David Ryan; Mark R Johnson; Dipender Gill; Fu Siong Ng
Journal:  Hypertension       Date:  2022-01-04       Impact factor: 9.897

3.  Periodontal disease and preterm delivery: a nationwide population-based cohort study of Taiwan.

Authors:  Ya-Ling Lee; Hsiao-Yun Hu; Sin-Yi Chou; Chen-Li Lin; Feng-Shiang Cheng; Chia-Yi Yu; Dachen Chu
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

4.  Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis.

Authors:  Hanglin Wu; Songying Zhang; Xiaona Lin; Jing He; Shasha Wang; Ping Zhou
Journal:  Reprod Biol Endocrinol       Date:  2021-11-04       Impact factor: 5.211

5.  Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.

Authors:  Maddalena Ardissino; Eric A W Slob; Fu Siong Ng; Dipender Gill; Skanda Rajasundaram; Rohin K Reddy; Benjamin Woolf; Joanna Girling; Mark R Johnson
Journal:  BMC Med       Date:  2022-09-06       Impact factor: 11.150

6.  To Explore the Application Effect and Value of Evidence-Based Nursing in Patients with Pregnancy-Induced Hypertension Syndrome.

Authors:  Xueying Han; Paul Froilan U Garma; Hongmei Quan; Yuqing Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-08-26       Impact factor: 3.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.